Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.
FDA Approves AbbVie Therapy for Adults with Advanced Parkinson’s Disease
Vyalev, also known as Produodopa, has been approved in 35 countries, with more than 4200 patients having started treatment.
